[Beta adrenergic blocking agents]. 1967

P Torsti

UI MeSH Term Description Entries
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents

Related Publications

P Torsti
January 1982, Journal of emergency nursing,
P Torsti
September 1982, Midwife, health visitor & community nurse,
P Torsti
March 1967, The New England journal of medicine,
P Torsti
May 1969, Il Policlinico. Sezione pratica,
P Torsti
January 1971, Journal of postgraduate medicine,
P Torsti
January 1976, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques,
P Torsti
May 1966, Nordisk medicin,
P Torsti
March 1970, Nihon rinsho. Japanese journal of clinical medicine,
P Torsti
October 1990, Journal of chromatography,
P Torsti
January 1984, Adverse drug reactions and acute poisoning reviews,
Copied contents to your clipboard!